Lithium as sole treatment vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Adjunctive lithium + antipsychotics may leads to higher response to treatment clinically relevant response as defined by the… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
It is very uncertain whether adjunctive lithium + antipsychotics changes acceptability of treatment leaving early due to any reason compared with placebo/no adjunctive treatment + antipsychotics (very low certainty).
Adjunctive lithium + antipsychotics showed no clear difference in clinically significant response on depressive symptoms at least 50%… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
Adjunctive lithium + antipsychotics showed no clear difference in clinically significant response on manic symptoms at least 50%… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
Adjunctive lithium + antipsychotics showed no clear difference in clinically significant response on positive symptoms at least 50% MS… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether metal-free FDPs (lithium disilicate) changes bridge complications compared with metal-ceramic FDPs (very low certainty).
It is very uncertain whether metal-free FDPs (lithium disilicate) changes bridge failure compared with metal-ceramic FDPs (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether mood stabilisers, including antiepileptics and lithium changes repetition of SH by post‐intervention№ of participants: 167(1 RCT) compared with placebo (very low certainty).